Risk of severe COVID-19 disease with ACE inhibitors and angiotensin receptor blockers: cohort study including 8.3 million people

BACKGROUND: There is uncertainty about the associations of angiotensive enzyme (ACE) inhibitor and angiotensin receptor blocker (ARB) drugs with COVID-19 disease. We studied whether patients prescribed these drugs had altered risks of contracting severe COVID-19 disease and receiving associated inte...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :Heart
Главные авторы: Hippisley-Cox, Julia, Young, Duncan, Coupland, Carol, Channon, Keith M, Tan, Pui San, Harrison, David A, Rowan, Kathryn, Aveyard, Paul, Pavord, Ian D, Watkinson, Peter J
Формат: Artigo
Язык:Inglês
Опубликовано: BMJ Publishing Group 2020
Предметы:
Special Populations
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC7509391/
https://ncbi.nlm.nih.gov/pubmed/32737124
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/heartjnl-2020-317393
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы